636 related articles for article (PubMed ID: 28640324)
1. New paradigms in venous thromboprophylaxis of medically ill patients.
Spyropoulos AC; Raskob GE
Thromb Haemost; 2017 Aug; 117(9):1662-1670. PubMed ID: 28640324
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of extended thromboprophylaxis for medically ill patients. A meta-analysis of randomised controlled trials.
Dentali F; Mumoli N; Prisco D; Fontanella A; Di Minno MN
Thromb Haemost; 2017 Feb; 117(3):606-617. PubMed ID: 28078350
[TBL] [Abstract][Full Text] [Related]
3. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
[TBL] [Abstract][Full Text] [Related]
4. Prevention of Venous Thromboembolism in Acutely Ill Medical Patients: A New Era.
MacDougall K; Spyropoulos AC
Semin Respir Crit Care Med; 2021 Apr; 42(2):308-315. PubMed ID: 33548931
[TBL] [Abstract][Full Text] [Related]
5. VTE primary prevention, including hospitalised medical and orthopaedic surgical patients.
Granziera S; Cohen AT
Thromb Haemost; 2015 Jun; 113(6):1216-23. PubMed ID: 25809340
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.
Bergmann JF; Cohen AT; Tapson VF; Goldhaber SZ; Kakkar AK; Deslandes B; Huang W; Anderson FA;
Thromb Haemost; 2010 Apr; 103(4):736-48. PubMed ID: 20135072
[TBL] [Abstract][Full Text] [Related]
7. Extended thromboprophylaxis for medically ill patients with decreased mobility: does it improve outcomes?
Sharma A; Chatterjee S; Lichstein E; Mukherjee D
J Thromb Haemost; 2012 Oct; 10(10):2053-60. PubMed ID: 22863355
[TBL] [Abstract][Full Text] [Related]
8. Perception of Chemical Venous Thromboprophylaxis for Oncologic Lung Resections among Thoracic Surgeons.
Malgor RD; Bilfinger TV; Blebea J; Ma H; Arnold SR
Ann Vasc Surg; 2017 Oct; 44():299-306. PubMed ID: 28479450
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective.
Spyropoulos AC; Ageno W; Cohen AT; Gibson CM; Goldhaber SZ; Raskob G
Thromb Haemost; 2020 Jun; 120(6):924-936. PubMed ID: 32492724
[TBL] [Abstract][Full Text] [Related]
10. Succinct review of the new VTE prevention and management guidelines.
Pollak AW; McBane RD
Mayo Clin Proc; 2014 Mar; 89(3):394-408. PubMed ID: 24582197
[TBL] [Abstract][Full Text] [Related]
11. Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet Need.
Korjian S; Daaboul Y; Halaby R; Goldhaber SZ; Cohen AT; Singh K; Susheela AT; Harrington RA; Hull RD; Hernandez AF; Gibson CM
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):227-32. PubMed ID: 26341120
[TBL] [Abstract][Full Text] [Related]
12. The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
Raskob GE; Spyropoulos AC; Zrubek J; Ageno W; Albers G; Elliott CG; Halperin J; Haskell L; Hiatt WR; Maynard GA; Peters G; Spiro T; Steg PG; Suh EY; Weitz JI
Thromb Haemost; 2016 Jun; 115(6):1240-8. PubMed ID: 26842902
[TBL] [Abstract][Full Text] [Related]
13. Prevention of venous thromboembolism through the implementation of a risk assessment tool: a comparative study in medical and surgical patients.
Park MY; Fletcher JP; Hoffmann C; Lance A; Gavegan F; Hitos K
Int Angiol; 2018 Oct; 37(5):411-418. PubMed ID: 29463079
[TBL] [Abstract][Full Text] [Related]
14. Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial.
Arabi YM; Alsolamy S; Al-Dawood A; Al-Omari A; Al-Hameed F; Burns KE; Almaani M; Lababidi H; Al Bshabshe A; Mehta S; Al-Aithan AM; Mandourah Y; Almekhlafi G; Finfer S; Abdukahil SA; Afesh LY; Dbsawy M; Sadat M
Trials; 2016 Aug; 17(1):390. PubMed ID: 27488380
[TBL] [Abstract][Full Text] [Related]
15. Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.
Barkoudah E; Piazza G; Hecht TEH; Grant P; Deitelzweig S; Fang MC; Fanikos J; Kao CK; Barnes GD; Chen T; Ramishvili T; Schnipper JL; Goldstein JN; Ruff CT; Kaatz S; Schwartz A; Connors JM; Goldhaber SZ
Am J Med; 2020 May; 133 Suppl 1():1-27. PubMed ID: 32362349
[TBL] [Abstract][Full Text] [Related]
16. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
Wiseman DN; Harrison J
N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta-Analysis.
Ho KM; Bham E; Pavey W
J Am Heart Assoc; 2015 Oct; 4(10):e002652. PubMed ID: 26504150
[TBL] [Abstract][Full Text] [Related]
18. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
19. Extended duration of thromboprophylaxis for medically ill patients: a systematic review and meta-analysis of randomised controlled trials.
Zayed Y; Kheiri B; Barbarawi M; Banifadel M; Abdalla A; Chahine A; Obeid M; Haykal T; Yelangi A; Malapati S; Bachuwa G; Seedahmed E
Intern Med J; 2020 Feb; 50(2):192-199. PubMed ID: 31276276
[TBL] [Abstract][Full Text] [Related]
20. External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system.
Rosenberg D; Eichorn A; Alarcon M; McCullagh L; McGinn T; Spyropoulos AC
J Am Heart Assoc; 2014 Nov; 3(6):e001152. PubMed ID: 25404191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
